Mission

ICER's mission is to lead innovation in comparative effectiveness research through methods that integrate considerations of clinical benefit and economic value.  Through a unique collaboration with patients, clinicians, manufacturers, insurers and other healthcare stakeholders, ICER develops tools to support patient decisions and medical policy that share the goal of achieving maximum value for every healthcare dollar.

TwitterLinkedinFacebookFeed
IMRT for Localized Prostate Cancer: Final Appraisal

ICER completed a comprehensive comparative effectiveness appraisal of IMRT for localized prostate cancer.